Skip to main content
Clinical Trials/NCT01592851
NCT01592851
Completed
Phase 3

A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Short Term Relief From Dentinal Hypersensitivity

GlaxoSmithKline1 site in 1 country113 target enrollmentApril 2012

Overview

Phase
Phase 3
Intervention
Stannous Fluoride
Conditions
Dentine Hypersensitivity
Sponsor
GlaxoSmithKline
Enrollment
113
Locations
1
Primary Endpoint
Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over a two week treatment period.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
May 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Arm 1

Dentifrice containing stannous fluoride

Intervention: Stannous Fluoride

Arm 2

Marketed dentifrice containing Sodium Monofluorophosphate

Intervention: Sodium Monofluorophosphate

Outcomes

Primary Outcomes

Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14

Time Frame: Baseline to Day 14

Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. Those teeth that met the tactile threshold inclusion criterion (tactile threshold ≤ 20g) were assessed at baseline and Day 14. The Investigator directed a second application of air from a standard dental syringe to the facial surface of the two sensitive teeth selected at baseline. The Schiff Sensitivity Score was calculated as the subject level mean change (on two teeth) from baseline.

Secondary Outcomes

  • Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale Immediately Post-treatment(Baseline to immediately post treatment administration)
  • Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3(Baseline to Day 3)
  • Change From Baseline in Tactile Pain Threshold Score at Day 14(Baseline to Day 14)
  • Change From Baseline in Tactile Pain Threshold Score at Day 3(Baseline to Day 3)
  • Change From Baseline in Tactile Pain Threshold Score Immediately Post-treatment(Baseline to immediately post treatment administration)

Study Sites (1)

Loading locations...

Similar Trials